These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 21355080

  • 1. Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma.
    Opel D, Naumann I, Schneider M, Bertele D, Debatin KM, Fulda S.
    Clin Cancer Res; 2011 May 15; 17(10):3233-47. PubMed ID: 21355080
    [Abstract] [Full Text] [Related]

  • 2. PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis.
    Bender A, Opel D, Naumann I, Kappler R, Friedman L, von Schweinitz D, Debatin KM, Fulda S.
    Oncogene; 2011 Jan 27; 30(4):494-503. PubMed ID: 20856197
    [Abstract] [Full Text] [Related]

  • 3. Bortezomib primes neuroblastoma cells for TRAIL-induced apoptosis by linking the death receptor to the mitochondrial pathway.
    Naumann I, Kappler R, von Schweinitz D, Debatin KM, Fulda S.
    Clin Cancer Res; 2011 May 15; 17(10):3204-18. PubMed ID: 21459798
    [Abstract] [Full Text] [Related]

  • 4. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
    Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S.
    Cancer Res; 2008 Oct 01; 68(19):7956-65. PubMed ID: 18829553
    [Abstract] [Full Text] [Related]

  • 5. Identification of a novel synthetic lethality of combined inhibition of hedgehog and PI3K signaling in rhabdomyosarcoma.
    Graab U, Hahn H, Fulda S.
    Oncotarget; 2015 Apr 20; 6(11):8722-35. PubMed ID: 25749378
    [Abstract] [Full Text] [Related]

  • 6. Synthetic lethal interaction between PI3K/Akt/mTOR and Ras/MEK/ERK pathway inhibition in rhabdomyosarcoma.
    Guenther MK, Graab U, Fulda S.
    Cancer Lett; 2013 Sep 01; 337(2):200-9. PubMed ID: 23684925
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
    Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Bhanot U, Hasel C, Möller P, Gschwend JE, Simmet T, Debatin KM, Fulda S.
    Cancer Res; 2009 Mar 15; 69(6):2425-34. PubMed ID: 19258513
    [Abstract] [Full Text] [Related]

  • 12. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
    Ravi R, Bedi A.
    Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014
    [Abstract] [Full Text] [Related]

  • 13. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis.
    Opel D, Westhoff MA, Bender A, Braun V, Debatin KM, Fulda S.
    Cancer Res; 2008 Aug 01; 68(15):6271-80. PubMed ID: 18676851
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
    Thanaketpaisarn O, Waiwut P, Sakurai H, Saiki I.
    Int J Oncol; 2011 Jul 01; 39(1):279-85. PubMed ID: 21537836
    [Abstract] [Full Text] [Related]

  • 17. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
    Bangert A, Cristofanon S, Eckhardt I, Abhari BA, Kolodziej S, Häcker S, Vellanki SH, Lausen J, Debatin KM, Fulda S.
    Oncogene; 2012 Nov 01; 31(44):4677-88. PubMed ID: 22266862
    [Abstract] [Full Text] [Related]

  • 18. Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL.
    El Fajoui Z, Toscano F, Jacquemin G, Abello J, Scoazec JY, Micheau O, Saurin JC.
    Gastroenterology; 2011 Aug 01; 141(2):663-73. PubMed ID: 21683075
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression.
    Fulda S, Meyer E, Debatin KM.
    Oncogene; 2002 Apr 04; 21(15):2283-94. PubMed ID: 11948412
    [Abstract] [Full Text] [Related]

  • 20. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K, Douglas L, Delaney A, Houghton JA.
    Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.